Nasdaq
$8.11▲ 2.08%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $367.8MShares out 45.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
36- 10.16After-hours26.10.17 06:004Ownership#●●●
MapLight Therapeutics, Inc.
Anatol Kreitzer, an insider at MapLight Therapeutics, reported a change in beneficial ownership of securities effective October 15, 2026. This filing serves as a standard Form 4 notification regarding insider equity holdings.…more
$8.11+2.08%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.16After-hours26.10.17 06:004Ownership
MapLight Therapeutics, Inc.
Insider Jonathan Gillis of MapLight Therapeutics, Inc. filed a Form 4 report regarding changes in beneficial ownership of securities as of October 15, 2026.…more
$8.11+2.08%vs prev closeView filingShare - 10.16After-hours26.10.17 06:004Ownership
MapLight Therapeutics, Inc.
Reporting person Lillie James Woodruff of MapLight Therapeutics, Inc. has changed their beneficial ownership of securities as of October 15, 2026. This filing serves as a formal Form 4 notification regarding insider equity transactions.…more
$8.11+2.08%vs prev closeView filingShare
35 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.6Pre-market26.10.06 20:00#●●●#●●●
MapLight Therapeutics Celebrates Co-Founder's 2026 Nobel Prize Win
MapLight Therapeutics co-founder Dr. Karl Deisseroth has been awarded the 2026 Nobel Prize in Physiology or Medicine for his foundational work in optogenetics. The company noted that this research serves as the core scientific basis for its proprietary circuit-based drug discovery platform.…more
$8.11+2.08%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.9After-hours26.09.10 06:34
●●●●●●●● ●●●●● ●●●●●●
MapLight Therapeutics has filed a prospectus for the potential resale of up to 13,181,055 common shares by existing stockholders. This filing indicates a potential increase in circulating supply, which may exert downward pressure on the stock price.…more
$8.11+2.08%vs prev closeShareBenzinga - 9.9Pre-market26.09.09 20:00
●●●●●●●● ●●●●● ●●●●●●
MapLight Therapeutics announced that its management team will participate in the Morgan Stanley 24th Annual Global Healthcare Conference. This event includes a presentation and one-on-one investor meetings, serving as a routine corporate update.…more
$8.11+2.08%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report